BrightSpring Health Services, Inc. (BTSG) shares rallied 12.6% in the last trading session to close at $20.89. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.6% gain over the past four weeks.BrightSpring Health Services recorded a strong price rise on investors’ optimism surrounding the company’s announcement of preliminary 2024 financial results. The company expects to report full year 2024 revenue betwee ...

On Monday, BrightSpring Health Services Inc BTSG agreed to sell its Community Living business, ResCare Community Living, to Sevita for $835 million in cash.The deal, set to close in 2025, aligns with BrightSpring’s strategic focus on enhancing its core services, including home health, hospice, primary care, rehabilitation, and pharmacy solutions.After the divestiture, the company expects to realize additional operational efficiencies across the BrightSpring platform, with a more synergistic overall portfoli ...

Transaction Overview - BrightSpring Health Services has entered into a definitive agreement to divest its Community Living business, ResCare Community Living, to Sevita for $835 million in cash consideration [1] - The transaction is expected to close in 2025, subject to regulatory approvals and typical closing conditions [1] - The divested Community Living business is expected to generate approximately $1.2 billion in Revenue and $128 million of Adjusted EBITDA in 2024 [8] Post-Divestiture Business Focus - Following the divestiture, BrightSpring's Provider Services will focus on Home Health and Hospice, Personal Care, Rehabilitation Services, and Primary Care [2] - The streamlined service offerings are expected to result in increased strategic focus, operational efficiencies, and greater clinical integration across the Provider Services and Pharmacy Solutions segments [4] - The transaction is expected to be accretive to both Company and Provider Services Revenue growth and Adjusted EBITDA growth [2] Financial Impact and Use of Proceeds - BrightSpring expects to realize approximately $715 million of after-tax cash proceeds from the transaction [9] - The net proceeds will primarily be used for debt paydown, strengthening the Company's balance sheet and reducing interest expense [9] - The divestiture is expected to increase Company Revenue and EBITDA Growth Rates and Cash Conversion, as well as Provider Services Revenue and EBITDA Growth Rates and Margin [7] Preliminary 2024 Results and 2025 Guidance - BrightSpring expects to report full year 2024 financial results above the guidance previously provided, with Net Revenue of $11,200 million to $11,300 million and Adjusted EBITDA of approximately $588 million [16] - For 2025, the Company is initiating guidance excluding the Community Living business, with Net Revenue expected to be $11,500 million to $12,000 million and Adjusted EBITDA expected to be $540 million to $555 million [17] Strategic Rationale - The divestiture allows BrightSpring to focus on a concentrated group of customers, patients, and stakeholders, maximizing exposure to target growth markets such as home health, rehab, primary care, hospice, and specialty and home and community pharmacy [4] - The transaction accelerates the Company's deleveraging path towards the long-term target of less than 3.0x [4] Industry and Company Background - BrightSpring Health Services is a leading provider of home and community-based pharmacy and health services for complex populations, serving over 400,000 customers, clients, and patients daily [19] - Sevita, the acquirer, has over 50 years of experience in providing home and community-based care for individuals with intellectual and developmental disabilities, serving 50,000 individuals in 40 states [20]

The Medical Services sector is experiencing significant transformation fueled by advancements in technology, increased adoption of value-based care and heightened focus on patient-centric solutions. Growing demand for remote treatment has led to a tremendous upsurge in digital healthcare options over the past few years. Demand for digital healthcare treatment continues to grow in the form of telemedicine-focused online medical and AI-powered technology services backed by the adoption of data and analytics. ...

LOUISVILLE, Ky., Dec. 11, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, completed the successful refinancing of all of its $2.55 billion Term Loan B facility due February 2031, through its subsidiary Phoenix Guarantor Inc. BrightSpring incurred no additional indebtedness as a result of the transaction. The Company’s refinanced facility was repriced at SOFR + ...

LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud of its specialty pharmacy partner, Onco360®, for being selected as the national pharmacy partner for multiple medications approved to treat advanced cancers and blood disease. “Our partner Onco360 is rapidly bringing innovative medicines and treatments to market to help improve the lives of patients living with once untreatable, rare diseases,” said Brigh ...

LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that Company management will participate at two upcoming virtual investor conferences. BTIG Virtual Digital Health Forum Panel on Monday, November 25th at 9:00AM ET Bank of America Virtual Home Care Conference 2024Fireside Chat on Tuesday, December 10th at 2:10PM ET A live and archived webcast of the Bank of America Home Care Conference Fireside Chat will be ...

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer’s disease. “We’re proud of the work CareMed is doing with manufacturers and prescribers to improve and extend the lives of patients living with mild cogni ...

BrightSpring Health Services, Inc. (NASDAQ:BTSG) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants Jennifer Phipps - Chief Accounting Officer Jon Rousseau - President & Chief Executive Officer Jim Mattingly - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies A.J. Rice - UBS David Larsen - BTIG Joanna Gajuk - Bank of America Ann Hynes - Mizuho Securities Whit Mayo - Leerink Linda Bolduc - Morgan Stanley Jamie Perse - Goldman Sachs Pito Chickering ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-41938 | --- | |----------------------------------------------------------------------------| | | | | | | | Delaware | | (Stat ...